The results exhibited that the nuclear NPL4 protein of the 4T1 cancer cells was significantly increased after treatment with DSF + CuCl2 or DSF@HCu compared with the control group, which was 3.63- or 2.53-fold that of control, respectively (Fig. 4j, k). This evidence concerns the gene NPLOC4 and cancer.